Use of green porphyrins to treat neovasculature in the eye
US5798349A · kind A · utility
116Cited by
2References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 17, 1995 |
| Grant date | Aug 25, 1998 |
| Priority date | — |
| Expiry date | Feb 17, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/0084
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Photodynamic therapy of conditions of the eye characterized by unwanted neovasculature, such as age-related macular degeneration, is effective using green porphyrins as photoactive agents, preferably as liposomal compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.